Pulmonary veno-occlusive disease Report of case and revision of the literature

Enfermedad pulmonar veno-oclusiva Reporte de un caso y revisión de la literatura

Published 2009-09-01

Open | Download
PDF (Spanish) FLIP
Issue
Vol. 21 No. 3 (2009)
Section
Presentación de casos
How to Cite
Pulmonary veno-occlusive disease Report of case and revision of the literature.
rev. colomb. neumol. [Internet]. 2009 Sep. 1 [cited 2024 Nov. 21];21(3):154-60.
DOI
license
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Andrés Jiménez Quijano
Cirujano de Tórax, Fundación Santa fe de Bogotá, Universidad El Bosque. Bogotá, Colombia
    Diana María Palacios Ortiz
    MD, Patóloga FSFB, Profesora asistente UN.
      Fidel Camacho Durán
      MD, FACS. Profesor de Cirugía y Director del Programa de Postgrado de Cirugía de Tórax, Universidad El Bosque. Jefe de la Sección de Cirugía de Tórax, Fundación Santa Fe de Bogotá. Bogotá, Colombia.
        Show authors biography

        The real incidence of veno-occulusive pulmonary disease (VOPD) is unknown because it is largely underdiagnosed or is not classified as primary pulmonary hypertension, being in fact a variant of the primary disease, primarily affecting post-capillary pulmonary vasculature. It is also known as isolated pulmonary venous sclerosis, obstructive disease of the pulmonary veins or primary pulmonary hypertension of the venous type.

        VOPD is the result of multiple aggressors associated to a great variety of risk factors. The diagnosis of the disease requires clinical, radiological and pathological features.

        Vasodilators, immunosuppressants, anticoagulation and oxygen have been proposed as treatments with a poor prognosis, and with reported survival limited by the scarce reporting of cases.

        We report a case of veno-occlusive pulmonary disease which was diagnosed in this institution.

        Article visits 380 | PDF visits 155

        Downloads

        Download data is not yet available.
        1. Weisser K,Wyler F;Pulmonary veno-occlusive disease: Arc Dis Child 1967;42:322-327.
        2. Rosenthal A, Vawter G,Intrapulmonary veno-occlusive disease. Am J Cardiol 1973;31:78-83.
        3. Mandel J, Mark E. Pulmonary veno-occlusive disease Am J Respir Crit Care Med 2000;162:1964-1973.
        4. Rubin Lj, Current concepts: primary pulmonary hypertension. N Engl J Med 1997;336:111-117.
        5. Wagenvoort CA. Pulmonary veno-occlusive disease: entity or syndrome Chest 1976;69:82-86.
        6. Brown CH, Harrison CV.Pulmonary veno-occlusive disease. Lancet 1966;2:61-65.
        7. Stovin PGI, Mitchinson MJ.Pulmonary hypertension due to obstruction of intrapulmonary veins. Thorax;1965;64:106-113.
        8. McDonnell PJ, Summer WR. Pulmonary veno-occlusive disease:morphological changes suggesting a viral cause. JAMA 1981;246:667-671.
        9. Escamilla R, Hertmant C.Pulmonary veno-occusive disease in HIV infected intravenous drug abuser. Eur Respir J.1995;8:1982-1984.
        10. Bjornsson J, Edwuars WD.Primary pulmonary hypertension a histophatologic study of 80 cases.Mayo Clin Proc.1985;60:16-25.
        11. Voordes CG, Kuipers JRG.Familial pulmonary veno-occlusive disease: a case report. Thorax 1977;32:763-766.
        12. Liu L, Sacler JP.A case of pulmonary veno-occlusive disease:ethiogical and therapeutic appraisal. Angiology 1973;32:299-304.
        13. Doll DC, Yarbro JW.Vascular toxicity associated with chemotherapy and hormonotherapy. Curr Opin Oncol 1994;6:345-350.
        14. Williams LM, Fussell S.Pulmonary veno-occlusive disease in adult following bone marrow transplantation. Chest 1996;109:1388-1391.
        15. Kumana CR, Ng M. Herbal Tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults. Gut 1985;26:101-104.
        16. Tsou E, Waldhorn RE: Pulmonary veno-occlusive disease in pregnancy. Obstet Gynecol 1984;64:281-284.
        17. Crissman JD, Koss M.Pulmonary veno-occlusive disease secondary to granulomatous venulitis. Am J Surg Pathol 1980;4:93-99.
        18. Morrasut PA, Walley VM.Pulmonary veo-occlusive disease and CREST variant of scleroderma. Can J cardiol 1992;8:1055-1058.
        19. Kishida Y, Kanai Y.Pulmonary veno-occlusive disease in a patient with LES. J Rheumatol 1993;20:2161-2162.
        20. Leinonen H, Krogerus L.Pulmonary veno-occlusive disease. Acta Med Scand 1987;221:307-310.
        21. Wagenvoort CA.Pulomnary veno-occlusive disease: involment of pulmonary arteries and review of the literature. Hum Pathol 1985;16:1033-1041.
        22. Carrington CB, Liedow AA.Pulmonary veno-occlusive disease. Hum Pathol 1978;73:321-324.
        23. Chawla SK, Kittle CF.Pulmonary veno-occlussive disease. Ann Thorax Surg 1976;22:249-253.
        24. Weinner JP, Goldstein R.Lack Association of pleural effusion with pulmonary arterial and right atrial hypertension. Chest 1987;92:967-970.
        25. Cheibel RL,Dedeker KL.Radiographic and angiorphic characteristics of pulmonary veno-occlusive disease. Radiology 1972;103:47-51.
        26. Worthy SA, Muller NL.Mossaic attenuation pattern on this section CT sacnas of the lung. Radiology 1997;205:465-470.
        27. De vries TW, Weening JJ.Pulmonary veno-occlusive disease. Eur Respir J 1991;4:1029-1032.
        28. Weed HG. Pulmonary capillary wedge pressure not the pressure in de pulmonary capillaries. Chest 1991;100:1138-1140.
        29. Ritch S, Kaufmann E.The effect of the high doses of calcium chanel blockers on survival in primary pulmonary hypertension. N Engl J Med.1992;327:76-81.
        30. Barst RJ, Ruin LJ.A comparition of continuous intravenous epoprostenol with conventional therapy for primary pulmonary hypertension. N Engl J Med.1996;334:296-302.
        31. Salzman GA, Rosa UW.Prolonged survival in pulmonary veno-occlusive disease treated with nifedipina. Chest1989;95:1154- 1156.
        32. Frank H, Mlezoch J.The effect of anticoagulant therapy in the primary and anorectic drug-induced pulmonary hypertension.Chest.1997;112:714-721.
        33. Report of the medical research council. Long term domiciliary oxygen therapy.Lancet 1981;28:681-686.
        34. Kramer MR, Estenne M.Radiation –induced pulmonary veno-occlusive disease. Chest 1993;104:1282-1284.
        35. Richardson PG, Elias AD.Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without toxicity in high-risk population.Blood 1998;92:737-744.
        36. Abecasis MM, Conceicao JP. Defibrotide as salvage therapy for refractory veno-occlusive disease for liver complicating allogeneic bone marrow transplantation. Bone Marrow Transplant. 1992;23:843-846.
        37. Barry W. Holcomb, Jr., Pulmonary Veno-occlusive Disease A Case Series and New Observations.Chest 2000;116:1671- 1675

        Information

        Journal history

        Keywords

        QR code

        Funding

        Support + Info: Here

         

         

        Directories and indexes

        Google Scholar profile

        Most read in the last 30 days

        Current Issue

        Sistema OJS 3.4.0.7 - Metabiblioteca |